Clene.com

  1. Home
  2. Clene.com

Patients Clene Inc.

WEBThe World Health Organization predicts neurodegenerative diseases will become the second-most prevalent cause of death within the next 20 years 1.With this sense of …

Actived: 7 days ago

URL: https://clene.com/patients/

Benjamin Greenberg, MD, MHS, FAAN Clene Inc.

WEB500 Principio Parkway West Suite 400 North East, Maryland 21901

Category:  Health Go Health

Science Clene Inc.

WEBThe Science. By transmitting thousands of energy-supportive electrons per second per nanocrystal, CNM-Au8® rapidly catalyzes NAD+. This catalytic reaction drives …

Category:  Health Go Health

Clene Inc. Nanomedicine in Pharmaceutical Research

WEBOur Pipeline. Our nanotherapeutic platform enables the creation of clean-surfaced, catalytically-active nanocrystals for therapeutic use. We are advancing a pipeline of …

Category:  Health Go Health

About CNM-Au8® Clene Inc.

WEBCNM-Au8 ®. Our lead drug candidate, CNM-Au8, is an oral suspension of clean-surfaced, catalytically-active gold nanocrystals. Resulting from a number of patented …

Category:  Health Go Health

About Us Clene Inc.

WEBMr. Hotchkin brings more than 20 years of experience in pharmaceutical commercialization, planning, strategy development, and medical affairs to Clene, where he currently leads …

Category:  Medical Go Health

ALS and MS Clinical Data from Clene’s CNM-Au8® Featured in …

WEBSALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene …

Category:  Health Go Health

Clene Welcomes New Shareholder Base and Announces Closing of

WEBInvestment led by Vivo Capital with participation from SymBiosis, Acuta Capital Partners, AIGH Capital, Serrado Capital LLC, and other new biotech investors, …

Category:  Health Go Health

Clene Nanomedicine Provides Clinical Program Update

WEBHealey ALS Platform Trial fully enrolled; top-line data expected 2H 2022 Significant survival benefit from RESCUE-ALS open label extension (OLE) Phase 2 trial …

Category:  Health Go Health

Clene Nanomedicine Initiates Phase 2 Study of CNM-ZnAg for …

WEBStudy to evaluate CNM-ZnAg in acutely symptomatic, non-hospitalized COVID-19 patients; SALT LAKE CITY, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Clene …

Category:  Health Go Health

Clene to Report HEALEY ALS Platform Trial Topline Results on …

WEBConference Call and Webcast Set for 8:30 a.m. EDT SALT LAKE CITY, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › M health surgery center mn

 › Healthshare hull phone number

 › Best air purifier for home health

 › Health safety and nutrition activities

 › Net zero health care building standard

 › Valley health wic locations

 › Valley health wic fax

 › Healthy low cal pasta recipes

 › Health canada regulatory framework

 › Valley health kanawha wv

Recently Searched

 › Johnson county health department dashboard

 › Centre for health protection health advice

 › Health care recruitment and retention

 › North carolina health maintenance department

 › Who owns my health record

 › Abound health hendersonville nc

 › Albania mental health articles

 › What is willett healthcare solutions

 › Denver health food center

 › Mental health act handbook